✦ LIBER ✦

DPP-4 inhibitors and GLP-1 analogues: for whom? Which place for incretins in the management of type 2 diabetic patients?

✍ Scribed by S. Halimi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Place of GLP-1–Based Therapy in Diab

✍ Eckerle Mize, Dara L.; Salehi, Marzieh 📂 Article 📅 2013 🏛 Current Science Inc. 🌐 English ⚖ 255 KB

Effectiveness of Switching from a DPP-4

✍ Farah, Lucette; Gourdy, Pierre; Charpentier, Guillaume; Martinez, Luc; Eschwege, 📂 Article 📅 2014 🏛 Canadian Diabetes Association 🌐 English ⚖ 50 KB

Specific actions of GLP-1 receptor agoni

✍ Stéphane Dalle; Rémy Burcelin; Pierre Gourdy 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 699 KB

Evaluating Second-Line Treatment Options

✍ Boland, C. L.; DeGeeter, M.; Nuzum, D. S.; Tzefos, M. 📂 Article 📅 2013 🏛 Harvey Whitney Books Company 🌐 English ⚖ 321 KB

Future perspectives for insulinotropic a

✍ B. Gallwitz; H.-U. Häring 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 583 KB

Pharmacokinetics, safety, and efficacy o

✍ Giorda, Carlo B.; Nada, Elisa; Tartaglino, Barbara 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 336 KB